Messenger

By ASHG President Gail Jarvik, MD, PhD We are continuing to experience a golden age in the field of human genetics. Each day we are making advances in technologies that are ushering in exciting opportunities. These are exciting times. The role of genetics in the evolution and treatment of cancer is being recognized and this... Read More

The pandemic and challenges of the past year have made clear how much science and research can impact every aspect of society, from public health and health equity to the economy. It is now more important than ever for scientists to engage with the public, including policymakers. The Government and Public Advocacy Committee (GPAC) is... Read More

Janine Austin Clayton, M.D., FARVO, is the Associate Director for Research on Women’s Health at the NIH and Director of the NIH Office of Research on Women’s Health (ORWH). Since assuming that role in 2012, Dr. Clayton has strengthened NIH support for research that affects the health of women throughout their lifespan and across the... Read More

ASHG is launching new public engagement and education initiatives to connect ASHG members with the public and share the benefits of human genetics and genomics research. Later this year, ASHG will launch its new Discover Genetics section on ASHG.org as part of the Society’s strategic goal to increase public awareness of the benefits and impact... Read More

ASHG extends sincere congratulations to its new 2021 board members and officers who began their terms on January 1.  The membership elected Charles Rotimi, PhD, National Institutes of Health as president-elect. The other new members of the Board of Directors are Claudia Gonzaga-Jauregui, PhD, Regeneron Pharmaceuticals; Heather Mefford, MD, PhD, St. Jude’s Children’s Research Hospital; Kiran Musunuru, MD, PhD, MPH, ML, University of Pennsylvania; and Ebony Shah-Williams, MS,... Read More